Kenya is set to redefine its HIV prevention strategy with the rollout of lenacapavir, a groundbreaking long-acting injectable that offers six months of protection against HIV with a single dose, marking one of the most significant advances in the fight against the epidemic in decades.
The move positions Kenya among the first nine African countries—alongside South Africa, Nigeria, Uganda, Zambia and Zimbabwe—to pioneer the twice-yearly injection under a Global Fund–backed funding guarantee, accelerating access to next-generation HIV prevention tools on the continent.
…CONTINUE READING
